Moreover, the acquisition of a mutation in DNMT3A followed by mutation in JAK2 was shown to lead to an ET phenotype, whereas the acquisition of the JAK2 mutation first was shown to result in a PV phenotype [124]. The gene discussed is DNMT3A; the disease is essential thrombocythemia.